These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 23029062

  • 1. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
    Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
    [Abstract] [Full Text] [Related]

  • 2. Epithelial cell transforming sequence 2 in human oral cancer.
    Iyoda M, Kasamatsu A, Ishigami T, Nakashima D, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2010 Nov 29; 5(11):e14082. PubMed ID: 21124766
    [Abstract] [Full Text] [Related]

  • 3. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
    Saito T, Kasamatsu A, Ogawara K, Miyamoto I, Saito K, Iyoda M, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2015 Nov 29; 10(9):e0137923. PubMed ID: 26378920
    [Abstract] [Full Text] [Related]

  • 4. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
    Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    Cancer Med; 2015 May 29; 4(5):759-69. PubMed ID: 25644496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
    Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2013 May 29; 8(12):e85951. PubMed ID: 24386490
    [Abstract] [Full Text] [Related]

  • 7. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2017 Apr 29; 486(2):385-390. PubMed ID: 28315328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma.
    Kim J, Kim MA, Jee CD, Jung EJ, Kim WH.
    Int J Cancer; 2009 Oct 15; 125(8):1842-50. PubMed ID: 19582876
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
    Kim JK, Kim PJ, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Shan JM, Ping WY, Park WS, Lee JY, Nam SW.
    Oncol Rep; 2010 Sep 15; 24(3):607-12. PubMed ID: 20664964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
    Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H, Tanzawa H.
    PLoS One; 2013 Sep 15; 8(2):e56381. PubMed ID: 23418564
    [Abstract] [Full Text] [Related]

  • 15. UNC93B1 promotes tumoral growth by controlling the secretion level of granulocyte macrophage colony-stimulating factor in human oral cancer.
    Wagai S, Kasamatsu A, Iyoda M, Hayashi F, Hiroshima K, Yoshimura S, Miyamoto I, Nakashima D, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2019 May 21; 513(1):81-87. PubMed ID: 30935694
    [Abstract] [Full Text] [Related]

  • 16. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
    Baba T, Sakamoto Y, Kasamatsu A, Minakawa Y, Yokota S, Higo M, Yokoe H, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    Mol Carcinog; 2015 Aug 21; 54(8):608-17. PubMed ID: 24375483
    [Abstract] [Full Text] [Related]

  • 17. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
    Shida-Sakazume T, Endo-Sakamoto Y, Unozawa M, Fukumoto C, Shimada K, Kasamatsu A, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2015 Aug 21; 10(3):e0120143. PubMed ID: 25803864
    [Abstract] [Full Text] [Related]

  • 18. Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
    Ishida S, Kasamatsu A, Endo-Sakamoto Y, Nakashima D, Koide N, Takahara T, Shimizu T, Iyoda M, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):339-345. PubMed ID: 28017725
    [Abstract] [Full Text] [Related]

  • 19. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
    Usukura K, Kasamatsu A, Okamoto A, Kouzu Y, Higo M, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    J Cancer Res Clin Oncol; 2013 Jan 29; 139(1):123-30. PubMed ID: 22986808
    [Abstract] [Full Text] [Related]

  • 20. GATA6 regulates expression of annexin A10 (ANXA10) associated with epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Takayama S, Morita Y, Nishimoto A, Nishimura J, Takebe K, Kishimoto S, Matsumiya-Matsumoto Y, Matsunaga K, Imai T, Uzawa N.
    Arch Oral Biol; 2022 Dec 29; 144():105569. PubMed ID: 36265396
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.